Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer (Q40108492)

17 September 2017

Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer (English)

1 reference

17 September 2017

1 reference

Graeme Walker

1

1 reference

17 September 2017

Kenneth MacLeod

2

1 reference

17 September 2017

Alistair R W Williams

3

1 reference

17 September 2017

David A Cameron

4

1 reference

17 September 2017

John F Smyth

5

1 reference

17 September 2017

Simon P Langdon

6

1 reference

17 September 2017

language of work or name

English

0 references

publication date

10 July 2007

1 reference

17 September 2017

1 reference

17 September 2017

106

1 reference

17 September 2017

3

1 reference

17 September 2017

461-468

1 reference

17 September 2017

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Hormonal therapy with letrozole for relapsed epithelial ovarian cancer. Long-term results of a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Tissue microarrays for high-throughput molecular profiling of tumor specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Aromatase expression in ovarian epithelial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

Aromatase inhibitors in the treatment of breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.009

10.1016/J.YGYNO.2007.05.009

7 January 2021

Identifiers

DOI

1 reference

17 September 2017

1 reference